URO ONCO

Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study

Kavalieris L, O'Sullivan P, Frampton C, Guilford P, Darling D, Jacobson E et al.

Editorial comment from Piotr Chlosta:
A novel noninvasive multigene urine biomarker test for the surveillance of bladder cancer recurrence, The Cxbladder Monitor, offers high sensitivity and high negative predictive value for ruling out urothelial carcinoma. Results suggest potential for deferring or avoiding cystoscopy in bladder cancer patients.

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.